Kalaris Therapeutics, Inc. — Key Metrics
1 years of history · ending 2019-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
Expense Ratios
Working Capital Analysis
ROIC vs WACC
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Stock Price on Earnings Dates
Kalaris Therapeutics, Inc. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 2.80% | -0.60% | 0.90% | 5.00% | 0.00% | 0.00% |
| Foreign Rate Differential | — | -25.60% | -1.30% | 8.30% | -0.10% | — |
| Other Adjustments | -0.10% | -0.50% | -0.60% | 0.60% | 0.50% | -0.50% |
| R&D Tax Credits | 1.70% | — | — | — | -0.50% | 0.90% |
| SBC (Nondeductible) | — | 1.40% | -2.70% | -2.40% | -10.80% | — |
| Valuation Allowance Change | -25.40% | -13.00% | -21.00% | -51.80% | -16.80% | -19.60% |
| Tax Law Change | — | — | — | -0.20% | -5.10% | — |
| Effective Tax Rate | — | -0.60% | 0.10% | 0.10% | 0.00% | 0.00% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | — | $1.0M | −$265.0K | −$126.0K | — | — |
| Income Taxes Paid (Cash) | — | — | $613.0K | $220.0K | — | — |